Education
About Us
Working with TipRanks
Follow Us
Predictmedix (PMEDF)
OTHER OTC:PMEDF
PMEDF Stock Chart & Stats
$0.04
$0.00(0.00%)
At close: 4:00 PM EST
$0.04
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.07
Previous CloseN/A
Volume20.00
Average Volume (3M)23.73K
Market Cap
$7.59M
Enterprise Value$11.06M
Total Cash (Recent Filing)$313.74K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta-1.10
Next Earnings
Jun 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding206,787,540
10 Day Avg. Volume12,646
30 Day Avg. Volume23,728
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-1.71
Price to Sales (P/S)0.00
P/FCF Ratio-61.13
Enterprise Value/Market Cap1.46
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-206.53
Enterprise Value/Ebitda-13.03
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
AI-driven Screening Product / Structural Industry TailwindsPredictmedix’s AI-driven contactless screening and remote-assessment platform targets workplace and public-entry health screening needs. Structural demand for digital health, contactless screening and remote diagnostics supports durable commercial opportunities and potential scalable deployments over time.
Low Reported Debt / Limited LeverageReported near-zero total debt provides financial flexibility despite ongoing losses. Low leverage reduces immediate interest obligations and preserves optionality to raise growth capital or pursue partnerships, a durable advantage versus highly leveraged peers during funding cycles.
Narrowing Cash Burn In Latest PeriodThe significant narrowing of cash burn in 2025 versus 2024 indicates improving operating efficiency or tighter cost controls. If sustained, lower burn improves runway and reduces near-term financing pressure, supporting longer-term operational stability and execution on product initiatives.
Bears Say
Negative Equity / Deteriorated Balance SheetStockholders’ equity turned negative by 2023 and stayed deeply negative in 2024–2025, reflecting accumulated losses. Negative equity constrains financial flexibility, can impede access to capital or partners, and raises solvency risk if operational performance does not improve.
Persistent Negative Cash FlowOperating and free cash flows are negative in every reported year, signaling chronic cash burn to fund operations. This structural cash deficit forces reliance on external financing, increases dilution risk, and undermines sustainability absent durable revenue growth or continued cost improvements.
Minimal, Inconsistent Revenue And Large LossesRevenue remains minimal and inconsistent while operating losses are large, demonstrating the business lacks a stable revenue base and proven monetization. Without consistent top-line growth and improved margins, the company’s path to profitability and scalable economics remains unproven.
Predictmedix News
PMEDF FAQ
What was Predictmedix’s price range in the past 12 months?
Predictmedix lowest stock price was $0.01 and its highest was $0.07 in the past 12 months.
What is Predictmedix’s market cap?
Predictmedix’s market cap is $7.59M.
When is Predictmedix’s upcoming earnings report date?
Predictmedix’s upcoming earnings report date is Jun 03, 2026 which is in 107 days.
How were Predictmedix’s earnings last quarter?
Predictmedix released its earnings results on Dec 19, 2025. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is Predictmedix overvalued?
According to Wall Street analysts Predictmedix’s price is currently Overvalued.
Does Predictmedix pay dividends?
Predictmedix does not currently pay dividends.
What is Predictmedix’s EPS estimate?
Predictmedix’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predictmedix have?
Predictmedix has 206,787,540 shares outstanding.
What happened to Predictmedix’s price movement after its last earnings report?
Predictmedix reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -28.571%.
Which hedge fund is a major shareholder of Predictmedix?
Currently, no hedge funds are holding shares in PMEDF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Predictmedix
Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offers disease symptom screening solutions to identify persons who are more likely to test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. The company also develops impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.
Technical Analysis
Imagin Medical
―
Perimeter Medical Imaging AI
―
Quipt Home Medical
―
VentriPoint Diagnostics
―
Cannabix Technologies
―
Ownership Overview
Options Prices
Currently, No data available
---